Congenital anomalies of the kidney and urinary tract (CAKUT) constitute 20% of all
congenital malformations occurring in one in 500 live births. Worldwide, CAKUT are …

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic
nephropathy, and tolvaptan is the only therapy available. However, tolvaptan slows but does …

There are an estimated 14,000 randomized trials published in chronic kidney disease. The
most frequently reported outcomes are biochemical endpoints, rather than clinical and …

Kidney cysts can manifest as focal disease (simple and complex kidney cysts), affect a
whole kidney (eg, multicystic dysplastic kidney or cystic dysplasia), or manifest as bilateral …

Abstract Autosomal Dominant Polycystic Kidney Disease (ADPKD) is common, with a
prevalence of 1/1000 and predominantly caused by disease-causing variants in PKD1 or …

Objectives The involvement of consumers (people with lived experience of disease) in
guidelines is widely advocated to improve their relevance and uptake. However, the …

The omission of outcomes that are of relevance to patients, clinicians, and regulators across
trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision …

Distinguishing autosomal‐dominant polycystic kidney disease (ADPKD) from other inherited
renal cystic diseases in patients with adult polycystic kidney disease and no family history is …

Background Enterococcus casseliflavus is a rare pathogenic bacterium that is characterized
by vancomycin resistance and can lead to multiple infections in the human body. This report …

Abstract Background Polycystic Kidney Disease (PKD) is a hereditary disorder that has no
cure and can result in end stage kidney failure. Searching for health information online and …